Trump Announces AstraZeneca Drug Price Cuts for Tariff Reprieve
President Trump has announced a deal with AstraZeneca Plc to lower consumer prices on some of the company's drugs in exchange for tariff relief. This is the second major agreement between the White House and a pharmaceutical company aimed at reducing healthcare costs for Americans. The deal will see AstraZeneca cut prices on certain drugs, though the specific details of the price reductions and the affected drugs have not been disclosed. In return, the company will receive tariff relief, which is intended to help offset the financial impact of the price cuts. The agreement is part of the Trump administration's ongoing efforts to address the high cost of prescription drugs in the United States. By negotiating such deals with pharmaceutical companies, the administration hopes to provide Americans with more affordable access to essential medications.
Source: For the complete article, please visit the original source link below.
